Pediatric Grand Rounds EM - Close to Closing the Loop in the Treatment of Type 1 Diabetes: A 100-Year Journey
Starts On:
Wed, 9/16, 2020: 12:00 AM
Ends On:
Thu, 6/30, 2022: 12:00 AM
Type:
Enduring Material
Credits:
1
Description:
ESTIMATED TIME TO COMPLETE: 60 minutes
Date of Review: 9/16/20
Termination Date: 6/30/22
ACCREDITATION INFORMATION
In support of improving patient care, The Robert Larner College of Medicine at the University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Vermont designates this Enduring Material activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been reviewed and is acceptable for up to 1 Nursing Contact Hours.
Date of Review: 9/16/20
Termination Date: 6/30/22
ACCREDITATION INFORMATION
In support of improving patient care, The Robert Larner College of Medicine at the University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Vermont designates this Enduring Material activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been reviewed and is acceptable for up to 1 Nursing Contact Hours.
Objectives:
At completion of the lecture, participants will:
1. Be able to identify the components of hybrid closed loop insulin therapy, summarize the benefits that it has on diabetes control, and recognize the limitations of the currently available closed loop systems.
1. Be able to identify the components of hybrid closed loop insulin therapy, summarize the benefits that it has on diabetes control, and recognize the limitations of the currently available closed loop systems.
Additional Resources:
Contacts:
Anna Zuckerman, MD
[email protected]
Penelope Marchessault
[email protected]
Contacts:
Anna Zuckerman, MD
[email protected]
Penelope Marchessault
[email protected]
Disclosure Information:
The planners, speaker and CMIE staff have no financial disclosures. This activity did not receive any commercial support.
Topic Categories:
Pediatrics
